Your account is not claimed yet. You can sign up with ORCID to claim your account.

Shoko Furukawa (S Furukawa)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Blood advances

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Masahiro Takeyama, Shoko Furukawa, Kenichi Ogiwara, Shinobu Tamura, Hitoshi Ohno, Satoshi Higasa, Naruto Shimonishi, Yuto Nakajima, Tomoko Onishi, Keiji Nogami
Coagulation potentials of plasma-derived factors VIIa and X mixture (Byclot ® ) evaluated by global coagulation assay in patients with acquired haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Kuniyoshi Mizumachi, Yuto Nakajima, Naruto Shimonishi, Shoko Furukawa, Kenichi Ogiwara, Masahiro Takeyama, Keiji Nogami
Hybrid human-porcine factor VIII proteins partially escape the inhibitory effects of anti-factor VIII inhibitor alloantibodies having A2 or C2 domain specificity. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Yuto Nakajima, Kenichi Ogiwara, Naruto Shimonishi, Shoko Furukawa, Masahiro Takeyama, Keiji Nogami
Intra-articular haemorrhage caused by reduced recovery of PEGylated recombinant factor VIII due to an anti-PEG antibody developed after mRNA-1273 SARS-CoV-2 vaccination in haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Naruto Shimonishi, Kenichi Ogiwara, Junko Yoshida, Kyoji Horie, Yuto Nakajima, Shoko Furukawa, Masahiro Takeyama, Keiji Nogami
Impaired factor V-related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations. Blood advances (2023)
Takahiro Yagyuu, Shoko Furukawa, Miki Zaizen, Sachiko Yata, Mitsuhiko Imada, Keiji Nogami, Tadaaki Kirita
Peri-operative hemostatic management of tooth extraction in patients with hemophilia A, with and without inhibitors, receiving emicizumab prophylaxis. Haemophilia : the official journal of the World Federation of Hemophilia (2022)
Shoko Furukawa, Keiji Nogami, Naruto Shimonishi, Yuto Nakajima, Taisei Matsumoto, Midori Shima
Prediction of the haemostatic effects of bypassing therapy using comprehensive coagulation assays in emicizumab prophylaxis-treated haemophilia A patients with inhibitors. British journal of haematology 190 (5) (2020)
Yuto Nakajima, Keiji Nogami, Koji Yada, Kenichi Ogiwara, Shoko Furukawa, Naruto Shimonishi, Midori Shima
Whole blood ristocetin-induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease. Haemophilia : the official journal of the World Federation of Hemophilia 25 (3) (2019)
Shoko Furukawa, K Nogami, H Yoshizawa, K Ogiwara, M Shima
Successful perioperative haemostatic management of aortic coarctation in a 5-week-old infant with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 23 (3) (2018)
Shoko Furukawa, Keiji Nogami, K Ogiwara, K Yada, M Shima
Successful prophylaxis using activated prothrombin complex concentrates (aPCC) in a severe haemophilia A patient with inhibitor previously unresponsive to on-demand daily infusions of aPCC. Haemophilia : the official journal of the World Federation of Hemophilia 23 (5) (2017)

Shoko Furukawa.css-eqlu8i{font-size:small;padding-left:4px;} (S Furukawa)

Publication Activity (10 Years)

Top Topics

Top Venues

Shoko Furukawa (S Furukawa)